Version August 2025
| BRCA1 variant | BRCA2 variant | |
| Female breast cancer | 57 to 66% | 45 to 61% |
| Male breast cancer | 0.2 to 1% | 2 to 7% |
| Ovarian cancer | 39 to 59% | 11 to 20% |
| Prostate cancer | 15 to 20% | 30 to 40% |
| Pancreatic cancer | 1 to 3% | 2 to 5% |
